Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
Michael Wilkinson, Associate Professor of Medicine at UC San Diego Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Current Atherosclerosis Reports, adding:
“Our timely, state-of-the-art review now published in Springer Nature Current Atherosclerosis Reports:
‘The Evolving Role of Coronary Artery Imaging in Assessing Cardiovascular Risk from Lipoprotein(a).’
- CAC scoring shows associations with Lp(a) incidence and progression, though findings across studies remain inconsistent.
- CCTA offers the most detailed noninvasive assessment, linking elevated Lp(a) to greater plaque prevalence, multivessel disease, and high-risk features like low-attenuation plaque, positive remodeling, and napkin-ring sign.
- Invasive imaging (OCT, IVUS) reinforces this, with elevated Lp(a) tied to thin-cap fibroatheroma, lipid-rich plaque, and greater atheroma progression over time.
There’s still a lot to learn about how Lp(a) uniquely shapes plaque biology and risk – this is a critical area for Lp(a) research in the coming years.”
Title: The Evolving Role of Coronary Artery Imaging in Assessing Cardiovascular Risk from Lipoprotein(a)
Authors: Michael T. Savides, Harpreet S. Bhatia, Inna Kuznetsova, Michael J. Wilkinson
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 10:01Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines
-
Aug 9, 2026, 08:18Fawaz AlOtaibi: Why Experts Are Challenging the New Stroke Guideline